According to the publication, the Worcester-based medical school says UMass Memorial Health owes it $40 million under a “revenue-sharing agreement,” in which the medical school claims it was supposed to receive a $40 million portion of revenue from the sale of specialty pharmacy company Shields Health Solutions.
Back in 2019, UMass Memorial sold its stake in Shields Health Solutions for $263 million.
UMass Memorial has called the medical school’s claims “baseless” and has been fighting the allegations.
The matter has since gone to arbitration, and according to two sources involved in the dispute, an arbitrator’s preliminary findings show the medical school could end up receiving far less than the $40 million it seeks.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
